Current Sarcoma News

Rein In Sarcoma's RSS news feeds are integrated from MedWorm.com, and contain links to studies and articles that are indexed with key words related to different types of sarcoma.

RSS MedWorm: Sarcomas

  • What is the incidence of suicide in patients with bone and soft tissue cancer? Suicide and sarcoma - Siracuse BL, Gorgy G, Ruskin J, Beebe KS. December 2, 2016
    BACKGROUND: Patients with cancer in the United States are estimated to have a suicide incidence that is approximately twice that of the general population. Patients with bone and soft tissue cancer often have physical impairments and activity limitations d... (Source: SafetyLit)MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best […]
  • Combo of cancer drugs shows promise against some tumors December 2, 2016
    HealthDay News Using a new cancer drug with an existing one appears to work against soft tissue sarcoma cancers, a new study indicates. (Source: Health News - UPI.com)
  • Leading Sarcoma Expert Dr. Earl W. Brien Joins CytRx Board of Directors December 2, 2016
    LOS ANGELES, Dec. 2, 2016 -- (Healthcare Sales & Marketing Network) -- CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today announced the appointment of Earl Warren Brien, M.D., a noted sarcoma sur... Biopharmaceuticals, Oncology, Personnel CytRx, Linker Activated Drug Release (Source: HSMN NewsFeed)
  • Drug Combo Shows Promise Against Some Soft Tissue Tumors December 2, 2016
    FRIDAY, Dec. 2, 2016 -- Using a new cancer drug with an existing one appears to work against soft tissue sarcoma cancers, a new study indicates. These cancers of soft tissues such as fat, muscles, blood vessels, tendons and ligaments are rare, but... (Source: Drugs.com - Daily MedNews)
  • Advanced soft tissue sarcomas respond to a combination of a new and an existing anti-cancer drug December 2, 2016
    Researchers working to find effective treatments for soft tissue sarcomas have discovered that combining a new anti-cancer drug with an existing one kills cancer cells not only in the laboratory but also in the first two patients treated with it, leading to unusually long-lasting periods without the disease progressing. (Source: ScienceDaily Headlines)
  • Drug Combo Shows Promise Against Some Soft Tissue Tumors December 1, 2016
    Adding new drug to standard one helped control sarcomas in early trial on 2 patients (Source: The Doctors Lounge - Oncology)MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.
  • Advanced soft tissue sarcomas respond to new drug GDC-0575 combined with gemcitabine December 1, 2016
    (ECCO-the European CanCer Organisation) Researchers working to find effective treatments for soft tissue sarcomas have discovered that combining a new anti-cancer drug with an existing one kills cancer cells not only in the laboratory but also in the first two patients treated with it, leading to unusually long-lasting periods without the disease progressing. Professor Antoine […]
  • The first analysis of Ewing's sarcoma methyloma opens doors to new treatments December 1, 2016
    (IDIBELL-Bellvitge Biomedical Research Institute) IDIBELL researchers describe the Ewing's sarcoma (ES) methylation profile for the first time.The methylation profile unveils the potential of the PTRF gene as a prognostic marker of the disease.The reestablishment of PTRF expression could serve as a therapeutic option in the future. (Source: EurekAlert! - Cancer)
  • Rare Sarcoma With TPM3-ALK Rearrangement May Respond to Ceritinib November 29, 2016
    A case study found that a patient with an inflammatory myofibroblastic tumor and a chromoplectic TPM3-ALK rearrangement that may be involved in tumorigenesis had a strong response to the ALK inhibitor ceritinib. (Source: CancerNetwork)
  • Investigators pinpoint cause, possible treatment for rare form of sarcoma November 22, 2016
    Researchers have discovered a potential cause and a promising new treatment for inflammatory myofibroblastic tumors, a rare soft tissue cancer that does not respond to radiation or chemotherapy. (Source: ScienceDaily Headlines)